Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04676022 · ClinicalTrials.gov registry record · NA
SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery
A NA study of Chronic Pain, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
- 20
- Study locations
NCT04676022: Completed NA study of Chronic Pain, sponsored by Boston Scientific Corporation.
NCT04676022 is a NA study of Chronic Pain that has completed, run by Boston Scientific Corporation. The registered enrollment target is 241 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (69% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04676022, a NA study of Chronic Pain, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
- 20
- Study locations
Study Summary
To evaluate the safety and effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities compared to Conventional Medical Management (CMM) in patients with chronic low back and/or leg pain who have not undergone spinal surgery when using the Boston Scientific WaveWriter SCS Systems.
Primary Outcome
Proportion of subjects with 50% or greater reduction in overall pain relief
Conditions Studied
Interventions
- DEVICE WaveWriter
- OTHER Conventional Medical Managament
Study Locations (20)
Louisiana
- MedPharmics, LLC - Metairie
- Ochsner Clinic Foundation - New Orleans
- Willis-Knighton River Cities Clinical Research Center - Shreveport
North Carolina
- Carolinas Research Institute, PLLC - Huntersville
- Novant Health-Hawthorne - Winston-Salem
- The Center for Clinical Research - Winston-Salem
California
- Vitamed Research - Palm Desert
- Summit Pain Alliance - Santa Rosa
Colorado
- Denver Back Pain Specialists - Greenwood Village
Florida
- South Lake Pain Institute, Inc - Clermont
Illinois
- University of Chicago Hospital - Chicago
Indiana
- Goodman Campbell Brain and Spine - Carmel
Kansas
- Crimson Pain Management - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2021-03-26 |
| Est. Completion | 2025-02-21 |
| Phase | NA |
What the finished NCT04676022 record still lists
NCT04676022 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which WaveWriter is the first listed.
NCT04676022 names 20 study sites across 15 states, led by Louisiana, North Carolina, California.
Frequently Asked Questions
What is clinical trial NCT04676022 about?
NCT04676022 is a clinical study titled "SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery". To evaluate the safety and effectiveness of Spinal Cord Stimulation (SCS) with multiple modalities compared to Conventional Medical Management (CMM) in patients with chronic low back and/or leg pain who have not undergone spinal surgery when using the Boston Scientific WaveWriter SCS Systems.
What is the current status of trial NCT04676022?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2021-03-26. Estimated completion is 2025-02-21.
What conditions does trial NCT04676022 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT04676022?
The interventions under investigation include: WaveWriter (DEVICE), Conventional Medical Managament (OTHER).
Who is sponsoring clinical trial NCT04676022?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04676022 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04676022's enrollment target sits among peer trials
241 67th of 301 higher than 235 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI